HomeNDC LookupRxCUI directory › RxCUI 861434

Clobetasol propionate 0.0005 MG/MG Topical Gel — RxCUI 861434

RxNorm drug concept · Semantic clinical drug
RxCUI 861434 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 31 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861434
Official nameClobetasol propionate 0.0005 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclobetasol propionate 0.05 % Topical Gel
FDA products mapped11
Package NDCs mapped31
Reported Medicaid activity (SDUD)115,436 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clobetasol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes — clobetasol is classified as a super-high potency steroid, which puts it in the strongest category of topical corticosteroids available. It's used for stubborn inflammatory sk...
  • What is clobetasol used for, and is it really that much stronger than other steroid creams?
  • Apply it to a dry scalp — not wet hair — in a thin film over the affected areas only. Leave it on for 15 minutes, then add water, lather, and rinse everything thoroughly, including...
  • How do I use the shampoo version correctly?
📖 Read our full Clobetasol Topical guide →

🕸️ Concept Web — How Clobetasol propionate 0.0005 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clobetasol propionate 0.0005 MG/MG Topical Gel RxCUI 861434

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Clobetasol 2590
    • Clobetasol propionate 21245
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clobetasol Topical Gel 379076
    • Clobetasol propionate Topical Gel 2649235
    • Clobetasol Topical Product 1153083
    • Clobetasol propionate Topical Product 2659863
    • Topical Gel 346286
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clobetasol propionate 0.0005 MG/MG 861433

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clobetasol propionate 0.0005 MG/MG SCDC · 861433
  • Clobetasol Topical Gel SCDF · 379076
  • Clobetasol propionate Topical Gel SCDFP · 2649235
  • Clobetasol Topical Product SCDG · 1153083
  • Clobetasol propionate Topical Product SCDGP · 2659863

📦 FDA Products & Package NDCs

11 products · 31 package NDCs
31 package NDCs map to RxCUI 861434 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0162-15 15 g in 1 TUBE (0168-0162-15) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-02-23
00168-0162-30 30 g in 1 TUBE (0168-0162-30) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-02-23
00168-0162-46 45 g in 1 TUBE (0168-0162-46) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-02-23
00168-0162-60 60 g in 1 TUBE (0168-0162-60) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-02-23
00168-0163-15 15 g in 1 TUBE (0168-0163-15) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-09-30
00168-0163-30 30 g in 1 TUBE (0168-0163-30) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-09-30
00168-0163-46 45 g in 1 TUBE (0168-0163-46) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-09-30
00168-0163-60 60 g in 1 TUBE (0168-0163-60) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 1996-09-30
00168-0293-15 15 g in 1 TUBE (0168-0293-15) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 2000-02-15
00168-0293-30 30 g in 1 TUBE (0168-0293-30) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 2000-02-15
00168-0293-60 60 g in 1 TUBE (0168-0293-60) Clobetasol Propionate E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 2000-02-15
45802-0925-14 1 TUBE in 1 CARTON (45802-925-14) / 15 g in 1 TUBE Clobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2008-07-30
45802-0925-94 1 TUBE in 1 CARTON (45802-925-94) / 30 g in 1 TUBE Clobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2008-11-11
45802-0925-96 1 TUBE in 1 CARTON (45802-925-96) / 60 g in 1 TUBE Clobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2008-07-31
51672-1258-01 1 TUBE in 1 CARTON (51672-1258-1) / 15 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-08
51672-1258-02 1 TUBE in 1 CARTON (51672-1258-2) / 30 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-08
51672-1258-03 1 TUBE in 1 CARTON (51672-1258-3) / 60 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-08
51672-1258-06 1 TUBE in 1 CARTON (51672-1258-6) / 45 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-08
51672-1259-01 1 TUBE in 1 CARTON (51672-1259-1) / 15 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-12
51672-1259-02 1 TUBE in 1 CARTON (51672-1259-2) / 30 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-12
51672-1259-03 1 TUBE in 1 CARTON (51672-1259-3) / 60 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-12
51672-1259-06 1 TUBE in 1 CARTON (51672-1259-6) / 45 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1996-07-12
51672-1294-01 1 TUBE in 1 CARTON (51672-1294-1) / 15 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1999-05-28
51672-1294-02 1 TUBE in 1 CARTON (51672-1294-2) / 30 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1999-05-28
51672-1294-03 1 TUBE in 1 CARTON (51672-1294-3) / 60 g in 1 TUBE Clobetasol Propionate Sun Pharmaceutical Industries, Inc. 1999-05-28
63629-8637-01 1 TUBE in 1 CARTON (63629-8637-1) / 15 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2008-07-30
63629-8638-01 1 TUBE in 1 CARTON (63629-8638-1) / 30 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2008-11-11
63629-8639-01 1 TUBE in 1 CARTON (63629-8639-1) / 60 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2008-07-31
72162-1438-02 1 TUBE in 1 CARTON (72162-1438-2) / 15 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2023-08-16
72162-1438-03 1 TUBE in 1 CARTON (72162-1438-3) / 30 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2023-08-16
72162-1438-06 1 TUBE in 1 CARTON (72162-1438-6) / 60 g in 1 TUBE Clobetasol Propionate Bryant Ranch Prepack 2023-08-16
Observed labelers: E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. (11) · Sun Pharmaceutical Industries, Inc. (11) · Bryant Ranch Prepack (6) · Padagis Israel Pharmaceuticals Ltd (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.